KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to -$4.7 million.

  • Pacira BioSciences' Other Working Capital Changes fell 193.94% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 66.09%. This contributed to the annual value of $7.4 million for FY2024, which is 23.64% down from last year.
  • Pacira BioSciences' Other Working Capital Changes amounted to -$4.7 million in Q3 2025, which was down 140.99% from $11.5 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Other Working Capital Changes registered a high of $11.5 million during Q2 2025, and its lowest value of -$4.7 million during Q3 2025.
  • In the last 3 years, Pacira BioSciences' Other Working Capital Changes had a median value of $2.4 million in 2023 and averaged $2.8 million.
  • Examining YoY changes over the last 5 years, Pacira BioSciences' Other Working Capital Changes showed a top increase of 1,777.17% in 2022 and a maximum decrease of 6,762.50% in 2022.
  • Over the past 5 years, Pacira BioSciences' Other Working Capital Changes (Quarterly) stood at -$3.8 million in 2021, then skyrocketed by 156.33% to $2.1 million in 2022, then grew by 24.50% to $2.7 million in 2023, then plummeted by 61.48% to $1.0 million in 2024, then slumped by 193.94% to -$4.7 million in 2025.
  • Its Other Working Capital Changes stands at -$4.7 million for Q3 2025, versus $11.5 million for Q2 2025 and $7.1 million for Q1 2025.